Correlation Between Stellar and Kymera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stellar and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stellar and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stellar and Kymera Therapeutics, you can compare the effects of market volatilities on Stellar and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stellar with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stellar and Kymera Therapeutics.

Diversification Opportunities for Stellar and Kymera Therapeutics

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Stellar and Kymera is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Stellar and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Stellar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stellar are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Stellar i.e., Stellar and Kymera Therapeutics go up and down completely randomly.

Pair Corralation between Stellar and Kymera Therapeutics

Assuming the 90 days trading horizon Stellar is expected to generate 2.11 times more return on investment than Kymera Therapeutics. However, Stellar is 2.11 times more volatile than Kymera Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 per unit of risk. If you would invest  38.00  in Stellar on October 20, 2024 and sell it today you would earn a total of  11.00  from holding Stellar or generate 28.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy90.91%
ValuesDaily Returns

Stellar  vs.  Kymera Therapeutics

 Performance 
       Timeline  
Stellar 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Stellar are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Stellar exhibited solid returns over the last few months and may actually be approaching a breakup point.
Kymera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kymera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Stellar and Kymera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stellar and Kymera Therapeutics

The main advantage of trading using opposite Stellar and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stellar position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.
The idea behind Stellar and Kymera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format